These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 312874)

  • 21. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
    Cass CE; Selner M; Tan TH; Muhs WH; Robins MJ
    Cancer Treat Rep; 1982 Feb; 66(2):317-26. PubMed ID: 6976834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse.
    Knudsen TB; Winters RS; Otey SK; Blackburn MR; Airhart MJ; Church JK; Skalko RG
    Teratology; 1992 Jan; 45(1):91-103. PubMed ID: 1731400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased NAD+ content in human T lymphoblastoid cells treated simultaneously with 2'-deoxycoformycin and 2'-deoxyadenosine.
    Koya M; Kanoh T; Uchino H; Ueda K
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1003-11. PubMed ID: 3877388
    [No Abstract]   [Full Text] [Related]  

  • 24. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
    Albert D; Bluestein HG; Thompson L; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells.
    Plagemann PG; Wohlhueter RM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6418-24. PubMed ID: 3877568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the effect of deoxyadenosine on deoxycoformycin-treated myeloid and lymphoid stem cells.
    Aye MT; Dunne JV; Yang WC
    Blood; 1982 Oct; 60(4):872-6. PubMed ID: 6981441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
    Seto S; Carrera CJ; Wasson DB; Carson DA
    J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes.
    Kefford RF; Fox RM
    Br J Haematol; 1982 Apr; 50(4):627-36. PubMed ID: 6978147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxyadenosine metabolism and toxicity in cultured L5178Y cells.
    Lowe JK; Gowans B; Brox L
    Cancer Res; 1977 Sep; 37(9):3013-7. PubMed ID: 301772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential production of deoxyadenosine by human T and B lymphoblasts.
    Iizasa T; Kubota M; Carson DA
    J Immunol; 1983 Oct; 131(4):1776-9. PubMed ID: 6352803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different relationships between cellular adenosine or 3'-deoxyadenosine phosphorylation and cellular adenine ribonucleotide catabolism may be obtained.
    Overgaard-Hansen K; Klenow H
    J Cell Physiol; 1993 Jan; 154(1):71-9. PubMed ID: 8419409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes.
    Snyder FF; Mendelsohn J; Seegmiller JE
    J Clin Invest; 1976 Sep; 58(3):654-66. PubMed ID: 956393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
    Adv Exp Med Biol; 1986; 195 Pt B():683-7. PubMed ID: 3490130
    [No Abstract]   [Full Text] [Related]  

  • 34. Adenosine-mediated killing of cultured epithelial cancer cells.
    Barry CP; Lind SE
    Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of adenosine deaminase by azapurine ribonucleosides.
    Shewach DS; Krawczyk SH; Acevedo OL; Townsend LB
    Biochem Pharmacol; 1992 Nov; 44(9):1697-700. PubMed ID: 1449528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia.
    Venner PM; Glazer RI; Blatt J; Sallan S; Rivera G; Holcenberg JS; Lipton J; Murphy SB; Poplack DG
    Cancer Res; 1981 Nov; 41(11 Pt 1):4508-11. PubMed ID: 6975654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxicity of deoxycoformycin: effect of constant infusion on adenosine deaminase, adenosine, 2'-deoxyadenosine and monoamines in the mouse brain.
    Helland S; Broch OJ; Ueland PM
    Neuropharmacology; 1983 Jul; 22(7):915-7. PubMed ID: 6604884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of deoxyadenosine on ribonucleotide reductase in adenosine deaminase-deficient lymphocytes.
    Takeda E; Kuroda Y; Naito E; Yokota I; Saijo T; Hirose M; Miyao M
    J Inherit Metab Dis; 1991; 14(1):87-95. PubMed ID: 1830628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
    Seto S; Carrera CJ; Kubota M; Wasson DB; Carson DA
    J Clin Invest; 1985 Feb; 75(2):377-83. PubMed ID: 2579098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.